Advertisement
Original article| Volume 55, ISSUE 6, P437-440, December 1996

Thromboxane A2 antagonist inhibits leukotriene D4-induced smooth muscle contraction in guinea-pig lung parenchyma, but not in trachea

  • H. Aizawa
    Correspondence
    Correspondence to: H. Aizawa, MD Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812, Japan.
    Affiliations
    Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashiku Fukuoka 812, Japan
    Search for articles by this author
  • H. Inoue
    Affiliations
    Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashiku Fukuoka 812, Japan
    Search for articles by this author
  • K. Matsumoto
    Affiliations
    Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashiku Fukuoka 812, Japan
    Search for articles by this author
  • H. Koto
    Affiliations
    Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashiku Fukuoka 812, Japan
    Search for articles by this author
  • H. Nakano
    Affiliations
    Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashiku Fukuoka 812, Japan
    Search for articles by this author
  • N. Hara
    Affiliations
    Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashiku Fukuoka 812, Japan
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Although the bronchoconstriction induced by leukotriene D4 (LTD4) has been reported to be partly mediated by thromboxane A2 (TXA2) in the guinea-pig airway, it is not known which part of the airway is susceptible to TXA2. In order to determine the role of TXA2 in the central and peripheral airways, we compared the effect of a TXA2 antagonist on tracheal strips to its effect on parenchymal strips of guinea-pigs. Tracheal and parenchymal strips were mounted in a 3.5 ml organ bath filled with Krebs-Henseleit solution aerated with 95% O2, 5% CO2 and kept at 37°C. After equilibration for 60 min in Krebs solution, the strip was contracted by exposure to 10−5 M of acetylcholine (ACh). Sixty minutes after ACh was eliminated, the concentration-response curve to LTD4 (10−9 M–10−7 M) was obtained, and the LTD4-induced contractions were expressed as the percent of the contraction evoked by 10−5 M of ACh. We measured the contractile response to LTD4 in the presence or absence of the TXA2 antagonist, BAY u3405 (10−8 M–10−6 M). In the tracheal strips, BAY u3405 had no effect on the LTD4-induced contraction. However, in parenchymal strips, BAY u3405 significantly suppressed the contractile response to LTD4. These results suggest that in the central airway LTD4 contracts smooth muscle directly, but that in the peripheral airway LTD4 induces smooth muscle contraction both directly and indirectly, via TXA2.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Prostaglandins, Leukotrienes and Essential Fatty Acids
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Adelroth E
        • Morris M.M
        • Hargreave F.E
        • O'Byrne P.M
        Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls.
        N Engl J Med. 1986; 315: 480-484
        • Piper P.J
        • Samhoun M.N
        Comparison of the actions of leukotriene E4 with those of leukotrienes B4,C4 and D4 on guinea pig lung and ileal smooth muscle in vitro.
        in: Samuelsson B Paoletti R Ramwell P.W Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Raven Press, New York1983: 127-131
        • Wasserman M.A
        • Weichman B.M
        • Woodward D.F
        • Muccitelli R.M
        • Gleason J.G
        Differentiation of the tracheal and lung parenchymal effects of synthetic leukotrienes in the guinea pig.
        in: Samuelsson B Paoletti R Ramwell P.W Advances in prostaglandin, Thromboxane, and Leukotriene Research. Raven Press, New York1983: 133-137
        • Ueno A
        • Tanaka K
        • Hirose R
        • Shishido M
        • Katori M
        Possible involvement of thromboxane in hypertensive and bronchoconstrictive effects of leukotriene C4 and D4.
        in: Samuelsson B Paoletti R Ramwell P.W Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Raven Press, New York1983: 139-144
        • Welton A.F
        • O'Donnell M
        • Anderson W
        • et al.
        Samuelsson B Paoletti R Ramwell P.W Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Raven Press, New York1983: 145-151
        • Drazen J.M
        • Schneider M.W
        Comparative responses of tracheal spirals and parenchymal strips to histamine and carbacol in vitro.
        J Clin Invest. 1978; 61: 1441-1447
        • Drazen J.M
        • Austen K.F
        Atropine modification of the pulmonary effects of chemical mediators in the guinea pig.
        J Appl Physiol. 1975; 38: 834-838
        • Hamberg M
        • Svensson J
        • Samuelsson B
        Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
        in: Proc Natl Acad Sci USA. 72. 1975: 2994-2998
        • Higgs G.A
        • Moncada S
        • Salmon J.A
        • Seager K
        The source of thromboxane and prostaglandins in experimental inflammation.
        Br J Pharmacol. 1983; 79: 863-868
        • Moncada S
        • Vane J.R
        Pharmacology and endogenous role of prostaglandin endoperoxide, thromboxane A2 and prostacyclin.
        Pharmacol Rev. 1979; 30: 293-331
        • Hamberg M
        • Svensson J
        • Wakabayashi T
        • Samuelsson B
        Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.
        in: Proc Natl Acad Sci USA. 71. 1974: 345-349
        • Svensson J
        • Strandberg K
        • Tuvemo T
        • Hamberg M
        Thromboxane A2 effacts on airway and vascular smooth muscle.
        Prostaglandins. 1977; 14: 425-436
        • Aizawa H
        • Chung K.F
        • Leikauf G.D
        • et al.
        Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs.
        J Appl Physiol. 1985; 59: 1918-1923
        • O'Byrne P.M
        • Leikauf G.D
        • Aizawa H
        • et al.
        Leukotriene B4 induced airway hyperresponsiveness in dogs.
        J Appl Physiol. 1985; 59: 1941-1946
        • Chung K.F
        • Aizawa H
        • Leikauf G.D
        • Ueki I.F
        • Evans T.W
        • Nadel J.A
        Airway hyperresponsiveness induced by platelet activating factor: role of thromboxane generation.
        J Pharmacol Exp Ther. 1986; 236: 580-584
        • Chung K.F
        • Aizawa H
        • Becker A.B
        • Frick O
        • Gold W.M
        • Nadel J.A
        Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY 046) in allergic dogs.
        Am Rev Respir Dis. 1986; 134: 258-261
        • Jones G.L
        • Saroea H.G
        • Watson R.M
        • O'Byrne P.M
        Effect of an inhaled thromboxane mimetic (U-46619) on airway function in human subjects.
        Am Rev Respir Dis. 1992; 145: 1270-1274
        • Chung K.F
        • Evans T.W
        • Graf P.D
        • Nadel J.A
        Modulation of cholinergic neurotransmission in canine airways by thromboxane mimetic U 46619.
        Eur J Pharmacol. 1985; 117: 373-375
        • Tamaoki J
        • Sekizawa K
        • Graf P.D
        • Nadel J.A
        Cholinergic neuromodulation by prostaglandin D2 in canine airway smooth muscle.
        J Appl Physiol. 1987; 63: 1396-1400
        • Shephard E.G
        • Malan L
        • Macfarlane C.M
        • Mouton W
        • Joubert J.R
        Lung function and plasma levels of thromboxane B2, 6-keto prostaglandin F and β-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment.
        Br J Clin Pharmacol. 1985; 19: 459-470
        • Seltzer J
        • Bigby B.G
        • Stulbarg M
        • et al.
        Ozone-induced changes in bronchial reactivity to methacholine and airway inflammation in humans.
        J Appl Physiol. 1986; 60: 1321-1326
        • Kirby J.G
        • Hargreave F.E
        • Cockroft D.W
        • O'Byrne P.M
        The effect of indomethacin on allergen-induced asthmatic responses.
        J Appl Physiol. 1989; 66: 578-583
        • Rosentreter U
        • Boshagen H
        • Seuter F
        • Perzborn E
        • Fiedler V.B
        Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropanoic acid and comparison with its enantiomer.
        Arzneim-Forsch/Drug Res. 1989; 39: 1519-1521
        • McKenniff M.G
        • Norman P
        • Cuthbert N.J
        • Gardiner P.J
        BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro.
        Br J Pharmacol. 1991; 104: 585-590
        • Norel X
        • Labat C
        • Gardiner P.J
        • Brink C
        Inhibitory effects of BAY u3405 on prostanoid-induced contractions in human isolated bronchial and pulmonary arterial muscle preparations.
        Br J Pharmacol. 1991; 104: 591-595
        • Francis H.P
        • Greenham S.J
        • Patel U.P
        • Thompson A.M
        • Gardiner P.J
        BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in guineapig.
        Br J Pharmacol. 1991; 104: 596-602
        • Johnston S.L
        • Bardin P.G
        • Harrison J
        • Ritter W
        • Joubert J.R
        • Holgate S.T
        The effects of an oral thromboxane TP receptor antagonist BAY u3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations.
        Br J Clin Pharmacol. 1992; 34: 402-408
        • Aizawa H
        • Shigyo M
        • Nogami H
        • Hirose T
        • Hara N
        BAY u3405, a thromboxane A2 antagonist, reduces bronchial responsiveness in asthmatics.
        Chest. 1996; 109: 338-342